Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study

Maria Rita Bongiorno, Maurizio Lombardo, Paolo Amerio, Maria Teresa Rossi, Andrea Chiricozzi, Serafinella Patrizia Cannavo’, Angelo Valerio Marzano, Francesca Prignano, Andrea Carugno, Claudio Feliciani, Marco Galluzzo, Andrea Conti, Luca Stingeni, Marina Talamonti, Concetta Potenza, Luca Bianchi, Stefano Piaserico, Aurora Parodi, Serafinella Patrizia Cannavo’, Giuseppe MicaliAndrea Conti, Concetta Potenza, Steven Paul Nisticò, Gabriella Fabbrocini, Pietro Quaglino, Francesco Loconsole, Maria Concetta Fargnoli, Iris Zalaudek, Sandra Giustini, Paola Savoia, Federico Bardazzi, Annamaria Offidani, Paolo Pigatto, Giuseppe Micali, Ketty Peris, Franco Rongioletti, Giuseppe Argenziano, Pietro Rubegni, Aurora Parodi, Paolo Gisondi, Giulia Rech

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds